Clinical Trials Logo

Opioid Craving clinical trials

View clinical trials related to Opioid Craving.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04238754 Completed - Opioid Use Disorder Clinical Trials

Oral Cannabidiol for Opioid Withdrawal

Start date: November 1, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This pilot study will examine the safety of the cannabinoid cannabidiol (Epidiolex) in a human laboratory model of clinically relevant withdrawal. The study will be a residential within-subject comparison; all participants will receive placebo dosing and active cannabidiol. Results may be used to support an R01 grant application to more closely examine this hypothesis.